Pulmonary hypertension right heart catheterization

Revision as of 16:35, 26 September 2011 by Ralph Matar (talk | contribs)
Jump to navigation Jump to search

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension right heart catheterization On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension right heart catheterization

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension right heart catheterization

CDC on Pulmonary hypertension right heart catheterization

Pulmonary hypertension right heart catheterization in the news

Blogs on Pulmonary hypertension right heart catheterization

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension right heart catheterization

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-in-Chief: Ralph Matar

Right heart Catheterization for pulmonary hypertension:

Cardiac catheterization is still the gold standard for diagnosing, assesing severity, and determining prognosis and response to therapy in pulmonary hypertension.

Right heart catheterization allows for determination of:

1-Presence or absence of pulmonary hypertension, define the underlying etiology, and determine the prognosis.

2- Prognostic markers such as right atrial pressure, cardiac output, and mean pulmonary artery pressure.

3- Pulmonary venous pressures by measuring pulmonary capillary wedge pressure (PCWP). Pulmonary arterial hypertension (PAH) is defined by a PCWP of 15 mmHg or less knowing that the normal PCWP or left ventricular end diastolic pressure (LVEDP) is less than 8 mmHg.

  • Fick’s method is reliable in patients with PAH for the measurement of cardiac output:



  • Since end-expiratory intrathoracic pressure most closely correlates with atmospheric pressure, it is important that all right ventricular, pulmonary artery, pulmonary wedge, and left ventricular pressures be measured at end-expiration
  • This procedure has been shown to be safe, with no deaths reported in the NIH registry study. In addition, a recent study reported a procedure-related mortality of 0.055%.


References


Template:WikiDoc Sources